X
Please Wait
Applying Filters...
01 AMLODIPINE BESYLATE; TELMISARTAN (4)
01 BOEHRINGER INGELHEIM (4)
01 TABLET;ORAL (4)
01 EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
03 EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
04 EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (4)
19
Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is AMLODIPINE BESYLATE; TELMISARTAN, with a corresponding application number 22401 and regulatory information .
proudly manufactured in the
approval since 2009-10-16
Boehringer Ingelheim GmbH's TWYNSTA TABLET;ORAL, medication with EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of AMLODIPINE BESYLATE; TELMISARTAN.
18
Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is AMLODIPINE BESYLATE; TELMISARTAN, with a corresponding application number 22401 and regulatory information .
proudly manufactured in the
approval since 2009-10-16
Boehringer Ingelheim GmbH's TWYNSTA TABLET;ORAL, medication with EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of AMLODIPINE BESYLATE; TELMISARTAN.
17
Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is AMLODIPINE BESYLATE; TELMISARTAN, with a corresponding application number 22401 and regulatory information .
proudly manufactured in the
approval since 2009-10-16
Boehringer Ingelheim GmbH's TWYNSTA TABLET;ORAL, medication with EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of AMLODIPINE BESYLATE; TELMISARTAN.
16
Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is AMLODIPINE BESYLATE; TELMISARTAN, with a corresponding application number 22401 and regulatory information .
proudly manufactured in the
approval since 2009-10-16
Boehringer Ingelheim GmbH's TWYNSTA TABLET;ORAL, medication with EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of AMLODIPINE BESYLATE; TELMISARTAN.
Market Place
